Tonix Pharma (TNXP) has provided an announcement.
Tonix Pharmaceuticals Holding Corp. has announced its transition to a fully integrated pharmaceutical company effective April 1, 2024. The announcement contains forward-looking statements about the company’s anticipated product development and market potential, but also cautions investors about the risks and uncertainties inherent in such predictions. These statements are not guarantees of future performance and are subject to change based on various factors detailed in the company’s SEC filings.
See more data about TNXP stock on TipRanks’ Stock Analysis page.
